Expand MRNA Menu
MRNA MENU

MRNA Latest Press Releases

-- September 27, 2024 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action MRNA Globe Newswire 5:19 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna Lawsuit - MRNA PRNewswire 5:45 AM

-- September 26, 2024 --

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry PRNewswire 6:00 AM
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PRNewswire 5:45 AM

-- September 25, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna Lawsuit MRNA Globe Newswire 11:53 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA PRNewswire 10:00 AM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 8:30 AM

-- September 24, 2024 --

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action MRNA Globe Newswire 1:37 PM
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action Contact The Gross Law Firm to Learn More Globe Newswire 12:58 PM
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PRNewswire 5:45 AM

-- September 23, 2024 --

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit PRNewswire 10:45 PM
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna PRNewswire 9:35 AM
Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA PRNewswire 5:45 AM
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline Globe Newswire 1:45 AM

-- September 22, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM

-- September 21, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM

-- September 20, 2024 --

Investors who lost money on Moderna, Inc. (MRNA) should contact Levi & Korsinsky about pending Class Action - MRNA PRNewswire 5:45 AM

-- September 19, 2024 --

Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights MRNA Globe Newswire 1:29 PM
The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA PRNewswire 5:45 AM

-- September 18, 2024 --

Moderna, Inc. REMINDER MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline Globe Newswire 6:48 PM
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join Contact The Gross Law Firm Globe Newswire 1:22 PM

-- September 17, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 4:20 PM
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older ACCESSWIRE 11:59 AM
Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA PRNewswire 10:38 AM
Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA PRNewswire 5:45 AM

-- September 16, 2024 --

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit PRNewswire 5:52 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline Globe Newswire 2:24 PM
Lost Money on Moderna, Inc. (MRNA)? Join Class Action Suit Seeking Recovery Contact Levi & Korsinsky Globe Newswire 12:46 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 8:30 AM
MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 5:45 AM

-- September 14, 2024 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 8:38 AM

-- September 13, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 5:45 AM

-- September 12, 2024 --

Moderna R&D Day Highlights Progress and Strategic Priorities ACCESSWIRE 10:43 AM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna PRNewswire 10:02 AM
Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA PRNewswire 5:45 AM

-- September 11, 2024 --

Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA) Globe Newswire 1:10 PM

-- September 10, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNA Globe Newswire 1:22 PM
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases PRNewswire 7:30 AM
Moderna, Inc. Class Action: Levi & Korsinsky Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA PRNewswire 5:45 AM

-- September 9, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline Globe Newswire 4:12 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA PRNewswire 3:30 PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 12:03 PM
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact The Gross Law Firm PRNewswire 10:26 AM
Moderna's Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada ACCESSWIRE 7:32 AM

-- September 8, 2024 --

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit PRNewswire 10:15 AM

-- September 6, 2024 --

MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 5:45 AM

-- September 5, 2024 --

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna PRNewswire 5:27 PM
Moderna, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information MRNA Globe Newswire 1:04 PM
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 12:04 PM
Moderna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA PRNewswire 5:45 AM

-- September 4, 2024 --

Moderna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company Seek Counsel Today Globe Newswire 10:54 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 Globe Newswire 8:30 AM

-- September 3, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm Globe Newswire 9:03 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA PRNewswire 3:19 PM
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1 ACCESSWIRE 8:48 AM
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PRNewswire 5:45 AM
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline Globe Newswire 1:45 AM

-- September 2, 2024 --

Taiwan Food & Drug Administration Approves Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 ACCESSWIRE 7:02 AM

-- September 1, 2024 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 7:52 PM

-- August 30, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit PRNewswire 3:35 PM

-- August 29, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact The Gross Law Firm PRNewswire 5:45 AM

-- August 28, 2024 --

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 3:33 PM
Shareholder Rights Law Firm Robbins LLP Urges Moderna, Inc. Stockholders to Seek Counsel for the MRNA Class Action Globe Newswire 3:04 PM
Shareholders that lost money on Moderna, Inc. (MRNA) Urged to Join Class Action Contact Levi & Korsinsky to Learn More Globe Newswire 12:33 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 8:30 AM
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer PRNewswire 6:30 AM

-- August 27, 2024 --

The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline MRNA Globe Newswire 12:51 PM
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Moderna, Inc. (NASDAQ: MRNA); Investors with Losses Encouraged to Discuss Their Options with Counsel Globe Newswire 12:10 PM
Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA PRNewswire 5:45 AM

-- August 26, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA PRNewswire 4:20 PM
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline Globe Newswire 11:15 AM
Class Action Filed Against Moderna, Inc. (MRNA) Seeking Recovery for Investors - Contact The Gross Law Firm PRNewswire 5:45 AM

-- August 24, 2024 --

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 4:27 PM

-- August 23, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Business Wire 8:00 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit PRNewswire 7:41 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R) ACCESSWIRE 7:01 AM
Lost Money on Moderna, Inc.(MRNA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PRNewswire 5:45 AM
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 ACCESSWIRE 1:25 AM

-- August 22, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! PRNewswire 8:00 PM
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2 ACCESSWIRE 1:47 PM
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join Contact Levi & Korsinsky Globe Newswire 1:18 PM
Moderna to Host Investor Event - R&D Day and Business Updates ACCESSWIRE 7:02 AM
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna, Inc. Lawsuit - MRNA PRNewswire 5:45 AM

-- August 21, 2024 --

October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNA Globe Newswire 1:19 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm Globe Newswire 12:00 PM

-- August 20, 2024 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 11:41 PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MNRA STOCK NEWS: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Moderna, Inc. Class Action Globe Newswire 8:08 PM
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- August 19, 2024 --

October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNA Globe Newswire 12:42 PM
Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 12:35 PM
MODERNA, INC. (NASDAQ: MRNA) INVESTOR ALERT: Investors With Large Losses in Moderna, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights Globe Newswire 12:30 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 10:00 AM
Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA PRNewswire 5:45 AM

-- August 18, 2024 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna and Sprinklr and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MRNA Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Moderna, Inc. Business Wire 5:59 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM

-- August 17, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA PRNewswire 10:00 AM

-- August 16, 2024 --

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 5:36 PM
Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA) PRNewswire 5:45 AM

-- August 15, 2024 --

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Business Wire 8:00 PM
The Gross Law Firm Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline PRNewswire 5:45 AM

-- August 14, 2024 --

MODERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Moderna, Inc. and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA Business Wire 8:41 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! PRNewswire 8:00 PM
Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA Globe Newswire 1:11 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm Globe Newswire 12:50 PM
Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 MRNA Globe Newswire 12:20 PM
Moderna and Coursera Launch Free Course on mRNA Technology ACCESSWIRE 7:01 AM

-- August 12, 2024 --

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna PRNewswire 7:00 PM
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Globe Newswire 4:00 PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action MRNA Globe Newswire 2:30 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Moderna Inc. (MRNA) Globe Newswire 1:55 PM
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 10:00 AM

-- August 10, 2024 --

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 3:53 PM

-- August 6, 2024 --

Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner PRNewswire 6:30 AM

-- August 2, 2024 --

MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm PRNewswire 10:00 AM

-- August 1, 2024 --

MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm Business Wire 7:33 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 6:55 PM
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates ACCESSWIRE 6:32 AM

-- July 29, 2024 --

GSK and Flagship Pioneering partner to discover novel medicines and vaccines PRNewswire 7:00 AM

-- July 25, 2024 --

Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World PRNewswire 8:00 AM

-- July 24, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 8:00 PM

-- July 23, 2024 --

David Rubenstein Joins Moderna's Board of Directors ACCESSWIRE 10:33 AM

-- July 18, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 6:26 PM

-- July 17, 2024 --

Alltrna Announces Updates to Its Board of Directors PRNewswire 8:00 AM

-- July 10, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 6:12 PM
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 ACCESSWIRE 7:01 AM
Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions PRNewswire 6:00 AM
Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability PRNewswire 6:00 AM

-- July 8, 2024 --

Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna's mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines ACCESSWIRE 7:02 PM

-- July 2, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 10:00 AM
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine ACCESSWIRE 7:30 AM

-- June 28, 2024 --

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna's RSV Vaccine, mRESVIA(R) ACCESSWIRE 7:01 AM

-- June 24, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 6:52 PM

-- June 15, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 12:45 PM

-- June 13, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA Globe Newswire 3:37 PM
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 Vaccine ACCESSWIRE 7:01 AM

-- June 12, 2024 --

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer PRNewswire 7:00 AM

-- June 10, 2024 --

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings Business Wire 10:00 AM
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19 ACCESSWIRE 6:30 AM

-- June 7, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 3:03 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA PRNewswire 3:03 PM
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine ACCESSWIRE 10:31 AM

-- June 6, 2024 --

Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program ACCESSWIRE 7:26 AM

-- June 5, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA Globe Newswire 5:19 PM

-- June 3, 2024 --

Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings Business Wire 5:46 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA Newsfile 5:21 PM
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection ACCESSWIRE 8:01 AM

-- May 31, 2024 --

Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) ACCESSWIRE 10:59 AM

-- May 22, 2024 --

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting ACCESSWIRE 7:01 AM

-- May 13, 2024 --

Moderna to Present at Upcoming Conferences in May/June 2024 ACCESSWIRE 7:01 AM

-- May 10, 2024 --

Moderna Announces Update on Investigational RSV Vaccine ACCESSWIRE 7:02 AM

-- May 9, 2024 --

Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management PRNewswire 7:00 AM

-- May 8, 2024 --

Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024 Globe Newswire 8:30 AM

-- May 7, 2024 --

Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome Business Wire 6:00 AM

-- May 2, 2024 --

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates ACCESSWIRE 6:33 AM